Your browser doesn't support javascript.
loading
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers.
Zhu, Vanessa; Burhenne, Jürgen; Weiss, Johanna; Haag, Mathias; Hofmann, Ute; Schwab, Matthias; Urban, Stephan; Mikus, Gerd; Czock, David; Haefeli, Walter E; Blank, Antje.
Afiliação
  • Zhu V; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Burhenne J; German Center for Infection Research (DZIF) Partner Site Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.
  • Weiss J; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Haag M; German Center for Infection Research (DZIF) Partner Site Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.
  • Hofmann U; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schwab M; German Center for Infection Research (DZIF) Partner Site Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.
  • Urban S; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Mikus G; University of Tübingen, Tübingen, Germany.
  • Czock D; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Haefeli WE; University of Tübingen, Tübingen, Germany.
  • Blank A; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Front Pharmacol ; 14: 1128547, 2023.
Article em En | MEDLINE | ID: mdl-37089922

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha